Position in REGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$484,490
-$353,824 QoQ
Shares Held
777
-28.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#814
of 1,322 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026waypoint wealth counsel holds $944,617 across 2 Biotechnology names. REGN ranks #1 (51.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
777 | $484,490 | |
| 2 | INCY |
Incyte Corp
|
4,059 | $460,127 |
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $484,490 | 777 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $838,314 | 1,085 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $835,162 | 1,082 | Shares | Other | 2026-01-28 | |
| 2025-09-30 | $548,774 | 976 | Shares | Sole | 2025-10-20 | |
| No filing history on record for this holder in this stock. | ||||||